Abstract:Gambogic acid (GA) has been shown to inhibit cancer cell proliferation, induce apoptosis, and enhance reactive oxygen species accumulation. However, whether GA could improve multidrug resistance through modulating autophagy has never been explored. We demonstrated that the combination of GA and cisplatin (CDDP) resulted in a stronger growth inhibition effect on A549 and NCI-H460 cells using the MTT assay. Furthermore, treatment with GA significantly increased autophagy in these cells. More importantly, GA-indu… Show more
“…It is reported that GA inhibited the growth of different types of cancer, including lung cancer, colorectal cancer, prostate cancer and breast cancer, hepatocellular carcinoma, multiple myeloma and leukemia. [14][15][16][17][18][19][20] The antitumor mechanism of GA may be related to inducing apoptosis, inhibiting telomerase, blocking NF-kB signaling pathway and enhancing the accumulation of reactive oxygen species. 21 However, the potential role and molecular mechanisms of GA in cervical cancer remain poorly understood.…”
“…It is reported that GA inhibited the growth of different types of cancer, including lung cancer, colorectal cancer, prostate cancer and breast cancer, hepatocellular carcinoma, multiple myeloma and leukemia. [14][15][16][17][18][19][20] The antitumor mechanism of GA may be related to inducing apoptosis, inhibiting telomerase, blocking NF-kB signaling pathway and enhancing the accumulation of reactive oxygen species. 21 However, the potential role and molecular mechanisms of GA in cervical cancer remain poorly understood.…”
“…Recent studies have shown that dysfunction in PTEN/PIK3/AKT/mTOR signaling is involved in tumorigenesis 36 . As an important tumor suppressor gene, PTEN negatively regulates PI3K/AKT/mTOR pathway, inhibiting cell growth and proliferation 37 , 38 . The findings in this study suggest that GA attenuates ESCC cell growth presumably through regulating PTEN and PI3K/AKT/mTOR pathway.…”
Esophageal squamous cell carcinoma (ESCC) is an invasive gastrointestinal malignancy and in urgent need of new effective therapies. Gambogic acid (GA) exhibits anti-cancer effects in many cancer cells, but it remains to be determined whether GA has the same effect on ESCC. Here, we reported that GA treatment caused an inhibition in ESCC cell proliferation, migration and invasion. Meanwhile, GA induced dose-dependent apoptosis of ESCC cells, repressed the expression of Bcl2 and up-regulated the levels of Bax protein, cleaved-PARP1 and cleaved-caspase 3/9. Further investigation showed that GA down-regulated the levels of PI3K, p-AKT and p-mTOR, while promoted PTEN expression in ESCC cells. Taken together, we provided the first demonstration that GA exerts anti-tumor effects on ESCC cells presumably through regulating PTEN-PI3K-AKT-mTORpathway, suggestive of a therapeutic potential for ESCC.
“…Gambogic Acid (GA) is a xanthonoid compound derived from Garcinia hanburyi with anti-cancer activity proved in vitro and in vivo [108].…”
Section: Gambogic Acidmentioning
confidence: 99%
“…The effect on cell death could be markedly reduced by the addition of autophagy inhibitors -3-MA and CQ. Moreover, treatment with GA was linked to Akt/mTOR pathway inhibition and the addition of mTOR inhibitor -rapamycin further increased autophagic flux and cell death [108].…”
Summary
Although cisplatin is one of the most common antineoplastic drug, its successful utilisation in cancer treatment is limited by the drug resistance. Multiple attempts have been made to find potential cisplatin chemosensitisers which would overcome cancer cells resistance thus improving antineoplastic efficacy. Autophagy modulation has become an important area of interest regarding the aforementioned topic. Autophagy is a highly conservative cellular self-digestive process implicated in response to multiple environmental stressors. The high basal level of autophagy is a common phenomenon in cisplatin-resistant cancer cells which is thought to grant survival benefit. However current evidence supports the role of autophagy in either promoting or limiting carcinogenesis depending on the context. This encourages the search of substances modulating the process to alleviate cisplatin resistance. Such a strategy encompasses not only simple autophagy inhibition but also harnessing the process to induce autophagy-dependent cell death. In this paper, we briefly describe the mechanism of cisplatin resistance with a special emphasis on autophagy and we give an extensive literature review of potential substances with cisplatin chemosensitising properties related to autophagy modulation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.